Logo

leukemia

BeiGene, CLL Society Partner to Promote Biomarker Testing in CLL, SLL

The partnership will support a campaign intended to increase the use of genomic testing to guide personalized therapy and improve outcomes.

Leukemia Subclones, Treatment Targets Spelled Out in Single-Cell Multiomics Study

Researchers teased out structural variants, intratumoral heterogeneity, and tumor subclone evolution in complex karyotype acute myeloid leukemia.

NeoGenomics Seeks to Serve Growing Demand for AML Biomarker Testing With Rapid NGS Panel
Premium

The company believes that it has threaded the needle in terms of providing the maximum of necessary information to clinicians, while maintaining a rapid turnaround time.

Invivoscribe LeukoStrat CDx Gets CE Mark, EMA Approval

The PCR-based test is designed to help in the selection of acute myelogenous leukemia patients eligible for certain treatments.

Qiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument
Premium

The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510(k) clearance along with a BCR-ABL assay.

Sep 4, 2024

Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment

Aug 15, 2024

Childhood Acute Lymphoblastic Leukemia Subtypes, Prognostic Features Uncovered in Genomic Study

Jun 27, 2024

Rarity Bioscience Building Oncology Test Portfolio on Highly Sensitive 'SuperRCA' Technology
Premium

Apr 19, 2024

Ex Vivo Drug Screening Identifies Personalized Treatments for Most Pediatric Cancer Patients in Trial
Premium

Mar 26, 2024

Childhood Leukemia Study Leads to Ancient Variant Linked to Population-Specific Risk

Mar 22, 2024

Bio-Techne Receives IVDR Certification for Chronic Myeloid Leukemia Test

Mar 19, 2024

Leukemia Trial to Assess DNA Methylation, Mutation Tests to Stratify Patients
Premium

Dec 10, 2023

Researchers Showcase New Scores, Biomarkers, Signatures for Predicting CAR T-Cell Outcomes at ASH
Premium

Dec 10, 2023

Polygenic Score May Help Personalize Induction Chemo, Improve Black Pediatric AML Patients' Outcomes

Sep 21, 2023

Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy

Sep 19, 2023

WUSTL Expands Patient Pool for WGS Cancer Test After CMS Coverage Milestone
Premium

Sep 13, 2023

Qlucore Moves Closer to IVDR Certification of Dx Software for Leukemia Testing
Premium

Jul 21, 2023

Invivoscribe Gets FDA Approval for LeukoStrat CDx for Daiichi Sankyo Leukemia Drug

May 30, 2023

Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring

May 11, 2023

Invivoscribe Leukemia CDx Assay Nabs IVDR Approval

Apr 26, 2023

Model Predicts Blood Cancer Progression Risk for Clonal Hematopoiesis Patients
Premium

Apr 18, 2023

Juntendo University, Sysmex, and ThinkCyte Collaborating on Tests, Treatments for CML

Apr 12, 2023

Function Oncology Launches With $28M, Seeks to Transform Precision Cancer Therapy With CRISPR
Premium

Mar 23, 2023

Baylor Team Aims to Identify Chemo Toxicity Biomarkers in Latino Pediatric Leukemia Patients
Premium

Mar 9, 2023

Servier, Qiagen to Develop PCR-Based Companion Diagnostic to Identify IDH1-Mutant Leukemia